SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Building Synergy between Regulatory and HTA Agencies beyond Processes and Procedures—Can We Effectively Align the Evidentiary Requirements? A Survey of Stakeholder Perceptions
5 references·0 citing·24 second hop
Building Synergy between Regulatory and HTA Agencies beyond Processes and Procedures—Can We Effectively Align the Evidentiary Requirements? A Survey of Stakeholder Perceptions (2017)Building Synergy between Regulatory and H…How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice (2016)How aligned are the perspecti…Methods of international health technology assessment agencies for economic evaluations- a comparative analysis (2013)Methods of international heal…Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions (2012)Commonalities and differences…Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers (2010)Relative efficacy of drugs: a…A rational framework for decision making by the National Institute For Clinical Excellence (NICE) (2002)A rational framework for deci…Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review (2015)Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety (2019)Cost-Benefit Analysis (2020)The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials (1997)Combination of direct and indirect evidence in mixed treatment comparisons (2004)Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies (2007)Access to orphan drugs despite poor quality of clinical evidence (2010)What principles should govern the use of managed entry agreements? (2011)Generating comparative evidence on new drugs and devices after approval (2020)WORLD HEALTH ORGANISATION (1957)A Coefficient of Agreement for Nominal Scales (1960)Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008)Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland (2016)Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries (2016)A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment? (2017)Markov Models in Medical Decision Making (1993)An Introduction to Markov Modelling for Economic Evaluation (1998)The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Expected Value of Sample Information Calculations in Medical Decision Modeling (2004)Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis (2006)Whither trial‐based economic evaluation for health care decision making? (2006)From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients (2015)
this work references cited by second hop

References

  • 2002A rational framework for decision making by the National Institute For Clinical Excellence (NICE)455 cited
  • 2010Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers174 cited
  • 2012Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions93 cited
  • 2013Methods of international health technology assessment agencies for economic evaluations- a comparative analysis87 cited
  • 2016How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice65 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work